ASCEND - The analyst's desk for self-directed investors

Ascend authors a living thesis for every stock you follow — and names the falsifiable criteria that would change its mind. Those criteria auto-resolve against earnings and news, so a thesis visibly holds or breaks over time. You get a 7am AI audio brief, deep reports, alerts when a thesis cracks, and an analyst you can ask anything. And we grade every call in public — including where we were wrong. Research, not advice.

Hey PH 👋 I'm Jordan, solo founder. I built Ascend because every investing tool does one of two things: hands you a score (a number with no reasoning) or a chatbot (an answer with no accountability). Neither shows its work. Ascend is different in one specific way. For every stock, it authors a real thesis and names the falsifiable criteria — the exact things that would change our mind — then auto-resolves them against earnings and news. So a thesis isn't a static PDF; it visibly holds or breaks. And there's a public scorecard of every call: what held, what broke, and where we were wrong. Nobody in this category publishes their misses. We do — that's the whole point. You're the portfolio manager; Ascend is your analyst's desk. It's research and education, not advice — I'm not telling you what to buy, I'm showing you the work I'd want to see before forming a view. Free to start on web and the App Store. I'll be here all day — tell me where it's wrong. 🙏

ASCEND - The analyst's desk for self-directed investors

Replies